Lifecore Biomedical, Inc. De (LFCR) Debt Ratio (2011 - 2025)

Lifecore Biomedical has reported Debt Ratio for 15 years, with the latest figure at 0.54 in Q2 2025.

• On a quarterly basis, Debt Ratio rose 10.33% year-over-year to 0.54 in Q2 2025; TTM through May 2025 was 0.54, a 10.33% increase from a year earlier, with the FY2025 full-year figure at 0.54, up 10.33% from the prior year.
• Debt Ratio was 0.54 for Q2 2025 at Lifecore Biomedical, up from 0.53 in the prior quarter.
• The five-year high for Debt Ratio was 0.74 in Q3 2022, with the low at 0.34 in Q2 2023.
• Average Debt Ratio over 5 years is 0.47, with a median of 0.41 recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Debt Ratio jumped 111.2% in 2022, then tumbled 52.87% in 2023.
• Over 5 years, Debt Ratio stood at 0.39 in 2021, then jumped by 81.79% to 0.72 in 2022, then slumped by 46.89% to 0.38 in 2023, then increased by 15.21% to 0.44 in 2024, then advanced by 24.19% to 0.54 in 2025.
• The last three Debt Ratio figures came in at 0.54 (Q2 2025), 0.53 (Q1 2025), and 0.44 (Q4 2024), per Business Quant data.